NCT00467558

Double-Blind Naltrexone in Compulsive Sexual Behavior

A Double-Blind, Placebo-Controlled Study of Naltrexone in Compulsive Sexual Behavior

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 7 (actual)
• Sponsor: University of Minnesota · Academic / Other
• Sex: All
• Age: 21 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in compulsive sexual behavior. Twenty subjects with DSM-IV compulsive sexual behavior will receive 8 weeks of naltrexone or placebo. The hypothesis to be tested is that naltrexone will be effective in reducing the urges to act out sexually in patients with compulsive sexual behavior. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.

Detailed description

The proposed study will consist of 8 weeks of treatment with either naltrexone or placebo in 20 subjects with compulsive sexual behavior.

Conditions

• Compulsive Sexual Behavior

Interventions

Type	Name	Description
DRUG	Naltrexone	daily
DRUG	Sugar pill	daily

Timeline

• Start date: 2007-05-01
• Primary completion: 2010-06-01
• Completion: 2010-06-01
• First posted: 2007-04-30
• Last updated: 2012-05-18
• Results posted: 2012-05-18

Locations

1 site across 1 country: United States